Semak Pharma to double investments in 2027, expand Fayoum production
Semak Pharmaceutical Group plans to double its current investment volume in 2027, with an expansion strategy focused on increasing production capacity, broadening its personal care portfolio and expanding distribution across Egyptian pharmacies. The company’s expansion plans centre on its manufacturing facility, Brand FSC (Brand Pharma), in Fayoum, which spans approximately 15,600 sqm. The…
Read original article on Dailynewsegypt →Related news
-
Egypt, Indonesia target $5bn in bilateral trade by 2030
-
World Bank Group mobilises $6.7bn in private capital for Egypt since FY2022
-
Egypt explores expanding health economics research with WifOR, Roche
-
Egypt’s chemical exports to Saudi Arabia surge 98% to $356m in 8M 2026
-
Youth Ministry, FRA sign MoU to promote entrepreneurship, fintech innovation
-
Madbouly reviews 2026/2027 development plan targeting 5.4% growth
-
Madinet Masr’s SAFE offers fractional real estate investment from EGP 5,000
-
Aqar Exit records EGP 8.8bn in deals as property listings reach EGP 124bn